請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23455完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 許輔 | |
| dc.contributor.author | Chih-Hsiang Chang | en |
| dc.contributor.author | 張智翔 | zh_TW |
| dc.date.accessioned | 2021-06-08T05:01:52Z | - |
| dc.date.copyright | 2010-08-02 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-05-03 | |
| dc.identifier.citation | 蔡明哲。2008。組合性保健食品配方免疫調節活性之研究。國立台灣大學園藝學
研究所碩士論文。 林宜信。2001。中醫診治法則與體質調理。藥膳保健食品研討會彙刊。 呂明方、王福大。2004。常用中草藥圖鑑。渡假出版社有限公司。P.27-28，P.187。 邱年永，張光雄。2003。原色台灣藥用植物圖鑑。南天書局有限公司。 (2): 248。 陳盈宜。2007。複方中草藥調節免疫及樟芝子實體抑制腫瘤之研究。國立台灣大 學園藝學研究所碩士論文。 陳原風。2001。中華民國、美國、日本與大陸保健食品管理方式之研究。國立海 洋大學食品科技學系碩士論文。 陳悅穎。2003。人蔘皂苷 Rh2 抗癌活性的研究。國立成功大學藥理學研究所碩 士論文。 陳雅琳。2004。複方五味子芝麻萃取物對於四氯化碳誘導大白鼠。台北醫學大學 保健營養學系碩士論文。 郭肇凱。2005。七種中草藥免疫調節功能之研究。國立台灣大學園藝學研究所碩 士論文。 張馨方。2005。銀杏、人參、五味子萃取物複方對四氯化碳誘發肝傷害老鼠肝功 能的影響。台北醫學大學保健營養學系碩士論文。 杜元平。2003。金針菇免疫調節蛋白 FIP-fve 抗腫瘤活性之探討。國立台灣大 學園藝學研究所碩士論文。 潘子明。2003。台灣地區機能性食品之管理與行銷狀況。生物醫學報導，第 21 期，27-34 頁。 劉新裕。1994。保健作物 : 綠茶。台灣農作要覽 : 農作篇 (一)。行政院農業委 員會。 Ahn, J.Y., Song, J.Y., Yun, Y.S., Jeong, G., and Choi, I.S. 2006. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immnol. Med. Microbiol. 46(2) : 187-97. Ali, S., and Roberts, PR. 2006. Nutrients with immune-modulating effects: what role should they play in the intensive care unit? Curr Opin Anaesthesiol. 19(2):132-9. Attele, A.S., Wu, J.A., and Yuan, C.S. 1999. Ginseng pharmacology. Biochem. Pharmacol. 58 : 1685-93. Briskin, D.P. 2000. Medicinal Plants and Phytomedicines. Linking Plant Biochemistry and Physiology to Human Health. Plant Physiol. Vol. 124. Chen, H.S., Tsai, Y.F., Lin, C.C., Khoo, K.H. Lin, C.H., and Wong, C.H. 2004. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg. Med. Chem. 12: 5595-5601. Chien, C.M., Cheng, J.L., Chang, W.T., Tien, M.H., Tsao, C.M., Chang, Y.H., Chang, H.Y., Hsieh, J.F., Wong, C.H., and Chen, S.T. 2004. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood. Bioorg Med Chem. 12(21):5603-9. Choi, E.M., Koo, S.J., and Hwang, J.K. 2004. Immune cell activity of monopolysaccharides isolated from yam (Dioscorea batatas). J. Ethnopharmacol. 91:1-6. Chu, D.C., and Juneja, L.R. 1997. General composition of green tea and its infusion. CRC Press, Boca Raton, pp.13.22. Fang, X., Chang, R.C., Yuen, W.H., and Zee, S.Y. 2005. Immune modulatory effects of Prunella vulgaris L. Int. J. Mol. Med. 15:491-6. Gao, Y., Gao, H., Chan, E., Tang, W., Xu, A., Yang, H., Huang, M., Lan, J., Li, X., Duan, W., Xu, C., and Zhou, S. 2005. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol Invest. 34(2):171-98. Garbacki, N., Tits, M., Angenot, L., and Damas, J. 2004. Inhibitory effects of Proanthocyanidins from Ribes nigrum leaves on carrageenin acute inflammatory reactions induced in rats. BMC Pharmacol. 4(1) : 25. Goldsby, R.A., Kindt, T.J., Osborne, B.A., and Kuby, J. 2002. Immunology. 4th ed. W. H. Freeman Co., New York. Graham, H.N. 1992. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 21(3): 334-350. Hakkinen, S., Heinonen, M., Karenlampi, S., Mykkanen, Ruuskamen, J., and Torronen, R. 1999. Screening of selected flavonoids and phenolic acids in 19 berries. Food Res. Int. 1999, 32, 345-353. Han, S.B., Yoon, Y.D., Ahn, H.J., Lee, H.S., Lee, C.W., Yoon, W.K., Park, S.K., and Kim, H.M. 2003. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int. Immunopharmacol. 3(9):1301-1312. Heinonen, I.M., Lehtonen, P.J., and Hopia, A.I. 1998. Antioxidant activity of berry and fruit wines and liquors. J. Agric. Food Chem. 46: 25-31. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., and Kromhout, D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet. 342: 1007-1011. Ho, C.T., Lee, C.Y., and Huang, M.T. 1992. Phenolic Compounds in Food and Their Effects in Health; American Chemical Society : Washington, DC. Jahn, B., Martin, E., and Stueben, A. 1995. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assas. J. Clin. Microbiol. 33: 661-667. Janeway, C.A., Travers, P., Walport, M., and Shlomichik, M.J. 2007. Immunobiology. 6th ed. Garland Publishing, New York. Kang, O.H., Chae, H.S., Choi, J.H., Choi, H.J., Park, P.S., Cho, S.H., Lee, G.H., So, H.Y., Choo, Y.K., Kweon, O.H., and Kwon, D.Y. 2006. Effects of the Schisandra fructus water extract on cytokine release from a human mast cell line. J Med Food. 9(4) : 480-486. Kim, H.A., Kim, S., Chang, S.H., Hwang, H.J., and Choi, Y.N. 2007. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int Immunopharmacol. 7(10) : 1286-1291. Kitts, D.D., and Hu, C. 2000. Efficacy and safety of ginseng. Public Health Nutrition : 3(4A): 473-485. Kobayashi, Y., Nakano, Y., Inayama, K., Sakai, A., and Kamiya, T. 2003. Dietary intake of the flower extracts of German chamomile (Matricaria recutita L.) inhibited compound 48/80-induced itch-scratch responses in mice. Phytomedicine. 10(8) : 657-664. Lee, B., Bae, E.A., Trinh, H.T., Shin, Y.W., Phuong, T.T., Bae, K.H., and Kim, D.H. 2007. Inhibitory effect of schizandrin on passive cutaneous anaphylaxis reaction and scratching behaviors in mice. Biol. Pharm. Bull. 30(6) : 1153-1156. Li, G.Z., Chai, O.H., and Song, C.H. 2005. Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis. Exp. Mo.l Med. 37(4) : 290-296. Lin, Z.B., and Zhang, H.N. 2004. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol. Sin. 25: 1387-1395. Liu, C.X., and Xiao, P.G. 1992. Recent advances on ginseng research in China. J. Ethnopharmacol. 36 : 27-38. Maday, E., Szentmihalyi, K., Then, M., and Szoke, E., 2000. Mineral element content of chamomile. Acta Aliment Hung 29: 51–57. Mann, C., and Staba, E.J. 1986. The chemistry, pharmacology, and commercial formulations of Chamomile. In Herbs, Spices, and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology Volume 1, Craker, L.E., and Simon, J.E. (eds). Oryx Press: Phoenix, 235–280 McKay, D.L., and Blumberg, J.B. 2006. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother. Res. 20, 519-530. Min, H.Y., Park, E.J., Hong, J.Y., Kang, Y.J., Kim, S.J., Chung, H.J., Woo, E.R., Hung, T.M., Youn, U.J., Kim, Y.S., Kang, S.S., Bae, K., and Lee, S.K. 2008. Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells. Bioorg. Med. Chem. Lett. 18(2) : 523-526. Mulinacci, N., Romani, A., Pinelli, P., Vincieri, F.F., and Prucher, D.. 2000. Characterization of Matricaria recutita L. flower extracts by HPLC-MS and HPLC-DAD analysis. Chromatographia 51 : 301–307. Pandey, R., Maurya, R., Singh, G., Sathiamoorthy, B., and Naik, S. 2005. Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn. Int. Immunopharmacol. 5(3):541-553. Puupponen-Pimia, R., Nohynek, L., Meier, C., Kahkonen, M., Heinonen, M., Hopia, A., and Oskman-Caldentey, K.M. 2001. Antimicrobial properties of phenolic compounds from berries. J. Appl. Microbiol. 90: 494-507. Weinberg, R. A., 2007. The biology of cancer. Garland Publishing, New York. Reid, D. 1995. A handbook of Chinese healing herbs. Shambhala Publishing USA. pp. 173-174. Shin, J.Y., Song, J.Y., Yun, Y.S., Yang, H.O., Rhee, D.K., and Pyo, S. 2002. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol. 24(3):469-82. Smolinski, A.T., and Pestka, J.J. 2003. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (Chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverew). Food Chem. Toxicol. 41(10) : 1381-1390. Takata, R., Yamamoto, R., Yanai, T., Konno, T., and Okubo, T. 2005. Immunostimulatory effects of a polysaccharide-rich substance with antitumor activity isolated from black currant (Ribes nigrum L.). Biosci Biotechnol Biochem. 69(11) : 2042-50. Wang, W., Rayburn, E.R., Hao, M. Zhao, Y., Hill, D.L., Zhang, R., and Wang, H. 2008. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate. 68(8) : 809-19. Watson, J.L., Vicario, M., Wang, A., Moreto, M., and McKay, D.M. 2005. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate. Cell Immunol. 237(1) : 7-16. Yamashita, K., Kagaya, M., Higuti, N., and Kiso, Y. 2000. Sesame seed and α-tocopherol synergisitically suppress lipid-peroxide in rats fed a high docosahexaenoic acid diet. Biofactors. 11:11-13. Yang, T., Jia, M., Meng, J., Wu, H., and Mei, Q. 2006. Immunomodulatory activity of polysaccharides isolated from Angelica sinensis. Int. J. Biol. Macromol. 39:170-184. Zaveri, N.T. 2006. Green tea and its polyphenolic catechins : Medicinal uses in cancer and noncancer applications. Life Sciences 78: 2073-2080. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23455 | - |
| dc.description.abstract | 本研究利用微米研磨技術針對人蔘 (Panax ginseng)、綠茶 (Camellia sinensis)、洋甘菊 (Camellia sinensis) 、金針菇 (Flammulina veluptipes) 等乾燥粉末調配得之組合性保健食品配方 J，處理得到微米化組合性保健食品配方 NJ，以 BALB/c 小鼠進行分析，餵食經過微米處理後之樣品與未經過微米處理之配方 J 其調節免疫與抑制小鼠肝腫瘤之活性之比較。
體內非特異性免疫調節活性結果顯示，餵食組合性保健食品配方J 高、中劑量 (分別為27.8 mg/mouse, 9.3 mg/mouse) 與微米化配方J (NJ) 高劑量可顯著提高小鼠脾細胞增生率 (p<0.05)；餵食配方 J 高劑量與微米配方 NJ 高劑量可顯著提升脾細胞 IFN-γ分泌量，而餵食配方 J 高中劑量可提高 IL-2分泌量 (p<0.05)；餵食配方 J 高中劑量可提高 NK 細胞毒殺活性 (p<0.05)；餵食配方 J 高中劑量與微米配方 NJ 高中劑量可顯著提升血液中單核球細胞吞噬能力 (p<0.05)；餵食配方 J 高劑量與微米配方 NJ 高中劑量可顯著提升小鼠血清中 IFN-γ 分泌量(p<0.05)；餵食配方 J 高中劑量與微米配方 NJ 高中劑量可顯著提升小鼠血清中總 IgG分泌量 (p<0.05)。由以上結果餵食組合性保健食品配方及其微米處理配方均具有調節非特異免疫反應之功效，但實驗數據顯示未經微米處理之配方 J 效果較佳。 體內 OVA 特異性免疫調節活性結果顯示，餵食配方 J 高劑量與微米配方 NJ 中劑量可顯著提高小鼠 OVA 特異性脾細胞增生率 (p<0.05)；餵食微米配方 NJ 高中劑量可顯著提昇脾細胞 OVA 特異性IFN-γ 分泌量 (p<0.05)，其中餵食 J 高劑量與微米配方 NJ 高中劑量亦可提高脾細胞 OVA 特異性 IL-2 分泌量 (p<0.05)。因此，餵食組合性保健食品配方及其微米處理配方具有調節 OVA 特異性免疫反應之功效。然而比較經過微米處理與否，配方 J 與經過微米處理配方 NJ在調節OVA特異性免疫之能力兩者並無顯著差異。 在抑制小鼠肝腫瘤試驗方面，以本實驗室純化所得之金針菇免疫調節蛋白 FIP-fve (0.2 mg/mouse) 作為正控制組，罹癌小鼠存活試驗顯示，腹腔注射ATCC BNL 1MEA.7R.1 肝癌細胞 (3×104 cell/mouse) 之BALB/c小鼠經餵食配方 J 高劑量與微米配方 NJ 高劑量，相較於未時對照組 (PBS)，可顯著延長小鼠存活時間 (p<0.05)。在非特異性抗腫瘤活性方面，結果顯示餵食配方 J 高中劑量與微米配方 NJ 中劑量可顯著活化腹腔巨噬細胞提升細胞激素 TNF-α 分泌量及 NO 之產生量；且小鼠腹腔巨噬細胞毒殺小鼠肝腫瘤細胞能力方面，餵食配方 J 高中劑量與微米配方 NJ 高中劑量與對照組相比皆具有顯著提升 (p<0.05)。在腫瘤特異性抗腫瘤活性方面結果顯示，餵食配方 J 高中劑量與微米配方 NJ 高中劑量均可顯著提高腫瘤特異性之小鼠脾細胞增生率 (p<0.05)；並顯著提升小鼠脾細胞之腫瘤特異性 IgG 分泌量 (p<0.05)；且小鼠脾臟細胞毒殺小鼠肝癌細胞能力，與對照組相比均具有顯著差異 (p<0.05)；餵食配方 J 高劑量與微米配方 NJ 高劑量可顯著提升小鼠脾臟細胞之腫瘤特異性 TNF-α 分泌量 (p<0.05)；餵食配方 J 高中劑量可顯著提升小鼠脾臟細胞之腫瘤特異性 IL-2 分泌量 (p<0.05)。然而比較經過微米處理與否，配方 J 與經過微米處理配方 NJ在調節腫瘤非特異性及腫瘤特異性抗腫瘤活性之能力兩者並無顯著差異，且均具有活化非特異性及腫瘤特異性之抑制小鼠肝腫瘤作用。 | zh_TW |
| dc.description.abstract | The objective of this study was to evaluate the immunomodulatory effects and anti-tumor effects of multi-ingredients health food formula J and micronized formula J (NJ). Results of the evaluation on non-specific immunomodulatory properties demonstrated that administration of formula J at high and medium doses (27.8 mg/mouse, 9.3 mg/mouse respectively) , as well as micronized formula J (NJ) at high doses (27.8 mg/mouse) significantly (p<0.05) enhanced the cell proliferation of mouse splenocytes. Administration of formula J and micronized formula NJ at high doses significantly (p<0.05) increased IFN-γ secretion by mouse splenocytes. Administration of formula J at high and medium doses significantly (p<0.05) increased the IL-2 secretion by mouse splenocytes. Administration of formula J at high and medium doses significantly (p<0.05) enhanced the NK cells activity of mouse splenocytes. Administration of formula J and micronized formula NJ (both at high and medium doses) significantly (p<0.05) enhanced the phagocytosis activity of monocytes. Administration of formula J (high dose) and micronized formula NJ (high and medium doses) significantly (p<0.05) increased the IFN-γ secretion in mouse sera. Administration of formula J and micronized formula NJ (both at high and medium doses) significantly (p<0.05) increased the total IgG secretion in mouse sera. These results showed that formula J was better then the micronized formula NJ on the non-specific immunomodulatory properties.
Results of the evaluation on OVA-specific immunomodulatory properties showed that administration of formula J (high dose) and micronized formula NJ (medium dose) significantly (p<0.05) enhanced the OVA-specific cell proliferation of mouse splenocytes. Administration of micronized formula NJ at high and medium doses significantly (p<0.05) increased OVA-specific IFN-γ secretion by mouse splenocytes. Administration of formula J (high dose) and micronized formula NJ (high and medium doses) significantly (p<0.05) increased the OVA-specific IL-2 secretion by mouse splenocytes. The objective was to investigate the anti tumor effects and its related mechanisms of formula J. Administration of formula J (high dose) and micronized formula NJ (high dose) significantly (p < 0.05) increased the life span of ATCC BNL 1MEA.7R.1 hepatoma-bearing mice (3×104 cells/mouse) by 30.2％ and 21.5％, respectively. This result suggested that formula J and micronized formula NJ displayed activities to suppress hepatoma growth in vivo. The results of non-specific anti-tumor activities showed that administration of formula J (high and medium doses) and micronized formula NJ (medium dose) significantly (p < 0.05) stimulated mouse peritoneal macrophages to secret TNF-α and produce nitric oxide. Additionally, the tumoricidal activity of peritoneal cells was also significantly enhanced (p < 0.05). Administration of formula J and micronized formula NJ (both at high and medium doses) significantly (p < 0.05) enhanced the tumor-specific cell proliferation of hepatoma-bearing mice splenocytes, and also significantly (p < 0.05) enhanced the tumor-specific IgG secretion in serum. Administration of formula J and micronized formula NJ (both at high doses) significantly (p < 0.05) increased the tumor-specific TNF-α secretion by hepatoma-bearing mice splenocytes. Administration of formula J at medium dose significantly (p < 0.05) increased the tumor-specific IL-2 secretion by hepatoma-bearing mice splenocytes. The tumoricidal activities of splenocytes cells obtained from hepatoma-bearing mice fed the formulas J and NJ samples were also significantly (p < 0.05) enhanced. These results showed that formula J and micronized formula NJ samples carried out anti-tumor activity by activating both the non-specific and tumor-specific immunities of their hosts. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T05:01:52Z (GMT). No. of bitstreams: 1 ntu-99-R96628211-1.pdf: 1388744 bytes, checksum: aa0276a7396e03c0aab083492fbef1ab (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 口試委員會審定書 .i
誌謝 .ii 中文摘要 .iii 英文摘要 .v 表目錄 …xiv 圖目錄 .xv 第一章 研究背景 第一節 前言 1 第二節 本研究所選用天然材料之相關研究 3 第三節 免疫系統 10 一、先天性免疫反應 11 (一)、物理性屏障 (anatomic barriers) 11 (二)、生理屏障 (physiologic barriers) 11 (三)、噬菌性屏障 ( phagocytic barriers) 11 (四)、發炎屏障 (inflammatory barriers) 11 二、後天性免疫反應 12 (一)、B 淋巴細胞 (B lymphocytes) 12 (二)、T 淋巴細胞 (T lymphocytes) 13 (三)、抗原呈獻細胞 (antigen-presenting cells) 14 三、自然殺手細胞 14 四、細胞激素 14 五、免疫球蛋白 (Immunoglobulin, Ig) 15 六、免疫調節與腫瘤抑制 17 (一)、先天性免疫反應於抗腫瘤所扮演角色 17 (二)、後天性免疫反應於抗腫瘤所扮演角色 18 第四節 研究動機與架構 18 第二章 材料與方法 第一節 材料來源 21 第二節 體內 (in vivo) 非特異性免疫調節活性分析 21 一、材料 21 (一)、原料. 21 (二)、化學藥品 21 (三)、設備與器材. 22 二、餵食組合性保健食品配方之試驗設計 23 三、對小鼠脾臟細胞之影響 24 (一)、分離小鼠脾臟細胞 24 (二)、細胞代謝活性試驗 (MTT assay) 24 (三)、淋巴細胞增生試驗 (BrdU assay) | |
| dc.language.iso | zh-TW | |
| dc.subject | 微米化 | zh_TW |
| dc.subject | 非特異性免疫調節活性 | zh_TW |
| dc.subject | 組合性保健食品 | zh_TW |
| dc.subject | OVA 特異性免疫調節活性 | zh_TW |
| dc.subject | 抗腫瘤 | zh_TW |
| dc.subject | micronization | en |
| dc.subject | anti-tumor activity | en |
| dc.subject | OVA-specific immunomodulatory activity | en |
| dc.subject | non-specific immunomodulatory activity | en |
| dc.subject | multi-ingredients health food formula | en |
| dc.title | 微米化保健食品配方免疫調節與抗腫瘤活性之研究 | zh_TW |
| dc.title | Studies on the Immunomodulatory Properties and
Anti-Tumor Effect of Micronized Health Food Formulas | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 顏國欽,周志輝,蔣恩沛 | |
| dc.subject.keyword | 微米化,組合性保健食品,非特異性免疫調節活性,OVA 特異性免疫調節活性,抗腫瘤, | zh_TW |
| dc.subject.keyword | micronization,multi-ingredients health food formula,non-specific immunomodulatory activity,OVA-specific immunomodulatory activity,anti-tumor activity, | en |
| dc.relation.page | 121 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2010-05-03 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 園藝學研究所 | zh_TW |
| 顯示於系所單位： | 園藝暨景觀學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 1.36 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。